Ibrutinib 140 mg Capsule is an anti-cancer medicine used to treat certain blood cancers, including Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Waldenström’s Macroglobulinemia (WM), and Marginal Zone Lymphoma (MZL). It belongs to a class of medicines known as Bruton’s Tyrosine Kinase (BTK) inhibitors.

Uses:

• Treatment of Mantle Cell Lymphoma (MCL)
• Treatment of Chronic Lymphocytic Leukemia (CLL) & Small Lymphocytic Lymphoma (SLL)
• Treatment of Waldenström’s Macroglobulinemia (WM)
• Treatment of Marginal Zone Lymphoma (MZL)

How it works:
Ibrutinib works by blocking the BTK enzyme, which cancer cells need to grow and survive. By stopping this signal, the medicine helps slow down or stop the growth of cancer cells.

Administration:

• Take orally, once daily with a glass of water
• Swallow the capsule whole; do not crush or open
• Take exactly as prescribed by your doctor

Side Effects (may include):

• Diarrhea, nausea, tiredness
• Muscle or joint pain
• Bruising or bleeding
• Rash or fever
• Rarely, heart rhythm problems or infections

Precautions:

• Use only under medical supervision
• Inform your doctor if you have bleeding disorders, heart problems, or liver disease
• Not recommended during pregnancy or breastfeeding unless advised by a doctor
• Avoid grapefruit or Seville oranges while on this medicine